# Incidence of Hypoxia During Intravitreal Anti-VEGF (Vascular Endothelial Growth Factor) Injections for Retinopathy of Prematurity (ROP) Under Topical Anesthesia

> **NCT07701759** · — · RECRUITING · sponsor: **Minia University** · enrollment: 74 (estimated)

## Conditions studied

- Retinopathy of Prematurity

## Interventions

- **DRUG:** ranibizumab

## Key facts

- **NCT ID:** NCT07701759
- **Lead sponsor:** Minia University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-01
- **Primary completion:** 2026-07-15
- **Final completion:** 2026-10-01
- **Target enrollment:** 74 (ESTIMATED)
- **Last updated:** 2026-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07701759

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07701759, "Incidence of Hypoxia During Intravitreal Anti-VEGF (Vascular Endothelial Growth Factor) Injections for Retinopathy of Prematurity (ROP) Under Topical Anesthesia". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07701759. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*